| Exhibit 99.1 KMG Chemicals, Inc. 9555 W. Sam Houston Parkway South Suite 600 Houston, TX 77099 USA �� |
KMG Reports Third Quarter 2015 Financial Results
HOUSTON, Texas—(BUSINESS WIRE)—June 9, 2015—KMG Chemicals, Inc. (NYSE: KMG), a global provider of specialty chemicals, today announced financial results for the fiscal 2015 third quarter ended April 30, 2015.
2015 Third Quarter Financial Highlights
· | Consolidated net sales were $74.0 million, a 12% decrease from last year’s third quarter. Sales declined due to the divestiture of the creosote business in January. |
· | Adjusted EBITDA1 increased to $9.1 million, up 20% from $7.6 million in last year’s third quarter. |
· | Adjusted diluted earnings per share2 was $0.35 vs. $0.20 per share reported in the prior year’s third quarter. |
· | GAAP EPS was $0.18 vs. $0.11 per share in the third quarter of fiscal 2014. |
· | Long-term debt balance at quarter end was $35 million, down from $39 million in the second quarter of fiscal 2015. During the third quarter, the company used cash generated from operations to reduce debt. |
Chris Fraser, KMG chairman and chief executive officer, said, “KMG had another solid quarter, reflecting continued strength in our North American Electronic Chemicals business and improved efficiency from the streamlining of our manufacturing operations, along with solid performance from our penta business. Adjusted EBITDA improved 20% from the same period last year, representing the fifth consecutive quarter of double-digit growth on a year‑over-year basis.
Mr. Fraser concluded, “We’re excited about our recent acquisition of Val-Tex, which provides KMG with an attractive new growth platform in the profitable and established market for industrial valve lubricants and sealants. As previously indicated, Val-Tex will be accretive to our fourth fiscal quarter adjusted EBITDA and adjusted diluted earnings per share. Consequently, we have increased our fiscal 2015 adjusted EBITDA guidance range to $35‑37 million, from $34-36 million previously.”
1 Non-U.S. GAAP measure. See Table 1 for reconciliation.
2 Non-U.S. GAAP measure. See Table 2 for reconciliation.
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
| | | | | | |
Third Quarter Results | | | | | | |
Dollars in thousands, except EPS | Fiscal 2015 | | Fiscal 2014 |
(unaudited) | | Adjusted | As Reported | | Adjusted | As Reported |
| | (non-GAAP) | (GAAP) | | (non-GAAP) | (GAAP) |
| | | | | | |
Net Sales | | $ 73,964 | $ 73,964 | | $ 84,437 | $ 84,437 |
Operating Income | | 6,299 | 4,761 | | 4,333 | 2,914 |
Operating Margin | | 8.5% | 6.4% | | 5.1% | 3.5% |
Net Income | | 4,099 | 2,135 | | 2,388 | 1,226 |
Diluted EPS | | $0.35 | $0.18 | | $0.20 | $0.11 |
Business segment results
| | | | | |
Electronic Chemicals | | | | | |
Third Quarter Results | | | | | |
Dollars in thousands | | Fiscal 2015 | | Fiscal 2014 |
| | As Reported | | Adjusted | As Reported |
| | (GAAP) | | (non-GAAP) | (GAAP) |
| | | | | |
Net Sales | | $ 66,388 | | $ 61,542 | $ 61,542 |
Operating Income | | 6,644 | | 3,429 | 3,175 |
Operating Margin | | 10.0% | | 5.6% | 5.2% |
For the third fiscal quarter, the Electronic Chemicals segment reported:
· | Sales of $66.4 million, up 7.9% from $61.5 million in the same period a year ago. Excluding the impact of foreign currency, third quarter fiscal 2015 sales were $70.5 million. The increase in reported sales reflects higher sales volume for high purity process chemicals in North America, partially offset by weakness in Europe. |
· | Adjusted EBITDA3 of $9.4 million, compared to $6.6 million last year. Foreign currency translation negatively impacted third quarter fiscal 2015 adjusted EBITDA by $400,000. |
· | GAAP operating income of $6.6 million vs. $3.2 million in the same period of fiscal 2014. Operating income improved due to increased sales volume, as well as benefits from the restructuring of our electronic chemicals operations. |
3 Non-U.S. GAAP measure. See Table 1 for reconciliation.
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
2
| | | | |
Wood Treating Chemicals | | | | |
Third Quarter Results | | | | |
Dollars in thousands | | Fiscal 2015 | | Fiscal 2014 |
| | As Reported | | As Reported |
| | (GAAP) | | (GAAP) |
| | | | |
Net Sales | | $ 7,566 | | $ 22,851 |
Operating Income | | 2,276 | | 2,092 |
Operating Margin | | 30.1% | | 9.2% |
For the third fiscal quarter, the Wood Treating Chemicals segment reported:
· | Sales of $7.6 million, versus $22.9 million in the same period a year ago. The sales decline reflects the divestiture of the creosote product line in January. |
· | EBITDA4 of $2.3 million, up from $2.2 million last year. |
· | Operating income of $2.3 million, or 30.1% of sales, compared to $2.1 million, or 9.2% of sales, last year. The increase in operating income was due to higher shipment volume and lower input costs in our Penta business, and the margin improved primarily due to the absence of creosote sales. |
Outlook
· | We narrow our fiscal 2015 consolidated net sales forecast to approximately $320 million versus our prior forecast of $315-325 million. Relative to the prior year, fiscal 2015 sales reflect growth in the Electronic Chemicals segment and the addition of Val‑Tex, with lower sales in the Wood Treating Chemicals segment due to the divestiture of the creosote product line. |
· | We increase our fiscal 2015 adjusted EBITDA forecast to $35-37 million, from $34-36 million previously. The increase in our adjusted EBITDA forecast includes the addition of Val-Tex. |
· | Fiscal 2015 depreciation and amortization expense is forecast to be approximately $14 million, excluding restructuring and realignment charges. |
· | Fiscal 2015 capital expenditures are forecast to be approximately $16 million, unchanged from our prior forecast. Capital expenditures include expenses related to our ERP system implementation, UPC integration and asset investments to support increased shipment volume in our Electronic Chemicals business. |
4 Non-U.S. GAAP measure. See Table 1 for reconciliation.
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
3
Conference call
Date: Tuesday, June 9, 2015
Time: 5:00 p.m. ET
Dial in: 877-440-1760 or 678-509-7570
Conference ID: 51067980
The conference call will be webcast live via the “Investors” section of the Company’s website at http://kmgchemicals.com.
If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 8:00 p.m. ET on June 9, 2015. To access the call, dial 855-859-2056 or 404-537-3406 using Conference ID 51067980.
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to select markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. For more information, visit the Company's website at http://kmgchemicals.com.
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
4
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
| | Three Months Ended | | | Nine Months Ended | |
| | April 30, | | | April 30, | |
| | | 2015 | | | | 2014 | | | | 2015 | | | | 2014 | |
Net sales | | $ | 73,964 | | | $ | 84,437 | | | $ | 244,505 | | | $ | 262,250 | |
Cost of sales | | | 47,149 | | | | 59,672 | | | | 161,544 | | | | 186,728 | |
Gross profit | | | 26,815 | | | | 24,765 | | | | 82,961 | | | | 75,522 | |
Distribution expenses | | | 11,700 | | | | 11,975 | | | | 37,721 | | | | 36,979 | |
Selling, general and administrative expenses | | | 9,257 | | | | 8,815 | | | | 28,164 | | | | 29,085 | |
Restructuring charges | | | 27 | | | | 1,061 | | | | 900 | | | | 5,092 | |
Realignment charges | | | 1,070 | | | | — | | | | 5,429 | | | | — | |
Operating income | | | 4,761 | | | | 2,914 | | | | 10,747 | | | | 4,366 | |
Other income (expense) | | | | | | | | | | | | | | | | |
Interest expense, net | | | (111 | ) | | | (926 | ) | | | (1,098 | ) | | | (2,250 | ) |
Gain (loss) on sale of creosote distribution business, net | | | (234 | ) | | | — | | | | 5,448 | | | | — | |
Other non-operating expense | | | (1,250 | ) | | | — | | | | (1,250 | ) | | | — | |
Other, net | | | (339 | ) | | | (105 | ) | | | (498 | ) | | | (540 | ) |
Total other income (expense), net | | | (1,934 | ) | | | (1,031 | ) | | | 2,602 | | | | (2,790 | ) |
Income before income taxes | | | 2,827 | | | | 1,883 | | | | 13,349 | | | | 1,576 | |
Provision for income taxes | | | (692 | ) | | | (657 | ) | | | (4,539 | ) | | | (1,742 | ) |
Net income (loss) | | $ | 2,135 | | | $ | 1,226 | | | $ | 8,810 | | | $ | (166 | ) |
Earnings per share | | | | | | | | | | | | | | | | |
Net income (loss) per common share basic | | $ | 0.18 | | | $ | 0.11 | | | $ | 0.75 | | | $ | (0.01 | ) |
Net income (loss) per common share diluted | | $ | 0.18 | | | $ | 0.11 | | | $ | 0.75 | | | $ | (0.01 | ) |
Weighted average shares outstanding | | | | | | | | | | | | | | | | |
Basic | | | 11,680 | | | | 11,634 | | | | 11,669 | | | | 11,606 | |
Diluted | | | 11,819 | | | | 11,673 | | | | 11,758 | | | | 11,606 | |
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
5
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
| | April 30, | | | July 31, | |
| | 2015 | | | 2014 | |
| | (Unaudited) | | | | | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 6,840 | | | $ | 19,252 | |
Accounts receivable | | | | | | | | |
Trade, net of allowances of $143 at April 30, 2015 and $272 at July 31, 2014 | | | 38,428 | | | | 40,176 | |
Other | | | 3,572 | | | | 1,904 | |
Inventories, net | | | 38,995 | | | | 45,268 | |
Current deferred tax assets | | | 1,351 | | | | 1,577 | |
Prepaid expenses and other | | | 3,873 | | | | 3,476 | |
Total current assets | | | 93,059 | | | | 111,653 | |
Property, plant and equipment, net | | | 80,702 | | | | 92,450 | |
Deferred tax assets | | | 442 | | | | 442 | |
Goodwill | | | 11,146 | | | | 12,595 | |
Intangible assets, net | | | 20,911 | | | | 28,353 | |
Restricted cash | | | 1,000 | | | | 1,000 | |
Other assets, net | | | 4,860 | | | | 4,365 | |
Total assets | | $ | 212,120 | | | $ | 250,858 | |
Liabilities and stockholders’ equity | | | | | | | | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 30,057 | | | $ | 36,690 | |
Accrued liabilities | | | 14,605 | | | | 16,986 | |
Employee incentive accrual | | | 4,238 | | | | 4,575 | |
Total current liabilities | | | 48,900 | | | | 58,251 | |
Long-term debt, net of current maturities | | | 35,000 | | | | 60,000 | |
Deferred tax liabilities | | | 5,146 | | | | 9,881 | |
Other long-term liabilities | | | 1,881 | | | | 2,520 | |
Total liabilities | | | 90,927 | | | | 130,652 | |
Commitments and contingencies | | | | | | | | |
Stockholders’ equity | | | | | | | | |
Preferred stock, $0.01 par value, 10,000,000 shares authorized, none issued | | | — | | | | — | |
Common stock, $0.01 par value, 40,000,000 shares authorized, 11,680,940 shares issued and outstanding at April 30, 2015 and 11,649,001 shares issued and outstanding at July 31, 2014 | | | 117 | | | | 116 | |
Additional paid-in capital | | | 30,866 | | | | 28,886 | |
Accumulated other comprehensive income (loss) | | | (8,107 | ) | | | 645 | |
Retained earnings | | | 98,317 | | | | 90,559 | |
Total stockholders’ equity | | | 121,193 | | | | 120,206 | |
Total liabilities and stockholders’ equity | | $ | 212,120 | | | $ | 250,858 | |
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
6
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
| | Nine Months Ended | |
| | April 30, | |
| | | 2015 | | | | 2014 | |
Cash flows from operating activities | | | | | | | | |
Net income (loss) | | $ | 8,810 | | | $ | (166 | ) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities | | | | | | | | |
Depreciation and amortization | | | 9,951 | | | | 10,422 | |
Non-cash restructuring and realignment charges | | | 5,640 | | | | 1,720 | |
Amortization of loan costs | | | 111 | | | | 45 | |
Stock-based compensation expense | | | 1,970 | | | | 1,777 | |
Bad debt expense | | | — | | | | 89 | |
Allowance for excess and obsolete inventory | | | 760 | | | | 33 | |
Gain on disposal of property | | | — | | | | (14 | ) |
Gain on sale of creosote distribution business | | | (5,448 | ) | | | — | |
Deferred income taxes | | | (4,374) | | | | 751 | |
Tax benefit from stock-based awards | | | (10 | ) | | | (328 | ) |
Changes in operating assets and liabilities | | | | | | | | |
Accounts receivable — trade | | | 95 | | | | 1,906 | |
Accounts receivable — other | | | (1,756 | ) | | | 538 | |
Inventories | | | 965 | | | | 7,277 | |
Other current and noncurrent assets | | | (1,386 | ) | | | 389 | |
Accounts payable | | | (4,897 | ) | | | (3,916 | ) |
Accrued liabilities and other | | | (2,219 | ) | | | 5,383 | |
Net cash provided by operating activities | | | 8,212 | | | | 25,906 | |
Cash flows from investing activities | | | | | | | | |
Additions to property, plant and equipment | | | (10,751 | ) | | | (7,133 | ) |
Disposals of property, plant and equipment | | | 2,561 | | | | 39 | |
Proceeds from sale of creosote distribution business | | | 14,899 | | | | — | |
Net cash provided by (used in) investing activities | | | 6,709 | | | | (7,094 | ) |
Cash flows from financing activities | | | | | | | | |
Net payments under revolving credit agreement | | | (41,100 | ) | | | (13,000 | ) |
Principal payments on term loan | | | (20,000 | ) | | | — | |
Borrowings under New Credit Facility | | | 59,100 | | | | — | |
Payments under New Credit Facility | | | (23,000 | ) | | | — | |
Tax benefit from stock-based awards | | | 10 | | | | 328 | |
Payment of dividends | | | (1,050 | ) | | | (1,043 | ) |
Net cash used in financing activities | | | (26,040 | ) | | | (13,715 | ) |
Effect of exchange rate changes on cash | | | (1,293 | ) | | | 356 | |
Net (decrease) increase in cash and cash equivalents | | | (12,412 | ) | | | 5,453 | |
Cash and cash equivalents at beginning of period | | | 19,252 | | | | 13,949 | |
Cash and cash equivalents at end of period | | $ | 6,840 | | | $ | 19,402 | |
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
7
Reconciliation of non-GAAP financial measures to GAAP financial measures
KMG provides non-GAAP financial information to complement reported GAAP results. KMG believes that analysis of our financial performance would be enhanced by an understanding of the factors underlying that performance and our judgments about the likelihood that particular factors will repeat. To provide for more accurate comparisons of the company’s operating performance, KMG’s non-GAAP financial measures exclude from current results: the gain on the sale of the creosote business; expenses related to acquisition and integration; restructuring and realignment of the Electronic Chemicals business; CEO transition expenses; and accruals related to environmental site cleanup. KMG intends to continue to provide certain non-GAAP financial information and the appropriate reconciliation to GAAP in its financial results. As required by SEC rules, the tables below present a reconciliation of our presented non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP measures should be viewed as a supplement to, and not a substitute for, U.S. GAAP measures of performance.
Table 1
RECONCILIATION OF OPERATING INCOME TO EBITDA AND ADJUSTED EBITDA
(in thousands)
| | | | |
Third Quarter Fiscal 2015 | Electronic | Wood Treating | |
| Chemicals | Chemicals | Corporate | Total |
| | | | |
Operating Income (Loss) | $6,644 | $2,276 | ($4,159) | $4,761 |
Other income (expense) | (193) | (37) | (109) | (339) |
Depreciation and amortization | 2,983 | 93 | 818 | 3,894 |
EBITDA | 9,434 | 2,332 | (3,450) | 8,316 |
| | | | |
Acquisition & integration expenses | - | - | 441 | 441 |
Restructuring & realignment charges* | - | - | 388 | 388 |
Adjusted EBITDA | $9,434 | $2,332 | ($2,621) | $9,145 |
* Excludes depreciation | | | | |
| | | | |
| | | | |
Nine Months Ended April 30, 2015 | Electronic | Wood Treating | |
| Chemicals | Chemicals | Corporate | Total |
Operating Income (Loss) | $16,335 | $6,456 | ($12,044) | $10,747 |
Other income (expense) | (76) | (90) | (332) | (498) |
Depreciation and amortization | 9,311 | 286 | 5,994 | 15,591 |
EBITDA | 25,570 | 6,652 | (6,382) | 25,840 |
| | | | |
Acquisition & integration expenses | - | - | 441 | 441 |
Restructuring & realignment charges* | - | - | 689 | 689 |
Adjusted EBITDA | $25,570 | $6,652 | ($5,252) | $26,970 |
* Excludes depreciation | | | | |
Phone: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
8
(Table 1 continued)
| | | | |
Third Quarter Fiscal 2014 | Electronic | Wood Treating | |
| Chemicals | Chemicals | Corporate | Total |
| | | | |
Operating Income (Loss) | $3,175 | $2,092 | ($2,353) | $2,914 |
Other income (expense) | (81) | 24 | (48) | (105) |
Depreciation and amortization | 3,202 | 104 | 1,053 | 4,359 |
EBITDA | 6,296 | 2,220 | (1,348) | 7,168 |
| | | | |
Acquisition & integration expenses | 254 | - | 104 | 358 |
Restructuring charges* | - | - | 112 | 112 |
Adjusted EBITDA | $6,550 | $2,220 | ($1,132) | $7,638 |
* Excludes depreciation | | | | |
| | | | |
| | | | |
Nine Months Ended April 30, 2014 | Electronic | Wood Treating | |
| Chemicals | Chemicals | Corporate | Total |
| | | | |
Operating Income (Loss) | $9,508 | $5,708 | ($10,850) | $4,366 |
Other income (expense) | (385) | (7) | (148) | (540) |
Depreciation and amortization | 9,794 | 300 | 2,048 | 12,142 |
EBITDA | 18,917 | 6,001 | (8,950) | 15,968 |
| | | | |
Acquisition & integration expenses | 914 | - | 104 | 1,018 |
CEO transition costs | - | - | 1,280 | 1,280 |
Restructuring charges* | - | - | 3,372 | 3,372 |
Adjusted EBITDA | $19,831 | $6,001 | ($4,194) | $21,638 |
* Excludes depreciation | | | | |
Main: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
9
Table 2
Reconciliation of Non-GAAP Financial Measures to GAAP Financial Measures
| | | | | | | | | |
Third Quarter Fiscal 2015 | | | | | | | | |
Dollars in thousands, except EPS | | KMG Chemicals, Inc. |
| | | | | | | | |
| | Operating | | Net | | Diluted Earnings |
| | Income | | Margin | | Income | | Per Share |
Non-GAAP measure | | $ 6,299 | | 8.5% | | $ 4,099 | | $0.35 |
Restructuring & realignment charges | | (1,097) | | (1.5%) | | (713) | | ($0.06) |
Acquisition & integration expenses | | (441) | | (0.6%) | | (287) | | ($0.03) |
Gain on sale of creosote business | | - | | 0.0% | | (152) | | ($0.01) |
Environmental site cleanup reserve | | - | | 0.0% | | (812) | | ($0.07) |
GAAP measure | | $ 4,761 | | 6.4% | | $ 2,135 | | $0.18 |
| | | | | | | | |
| | | | | | | | |
Nine Months Ended April 30, 2015 | | | | | | | | |
Dollars in thousands, except EPS | | KMG Chemicals, Inc. |
| | | | | | | | |
| | Operating | | Net | | Diluted Earnings |
| | Income | | Margin | | Income | | Per Share |
Non-GAAP measure | | $ 17,517 | | 7.2% | | $ 10,482 | | $0.89 |
Restructuring & realignment charges | | (6,329) | | (2.6%) | | (4,114) | | ($0.35) |
Acquisition & integration expenses | | (441) | | (0.2%) | | (287) | | ($0.02) |
Gain on sale of creosote business | | - | | 0.0% | | 3,541 | | $0.30 |
Environmental site cleanup reserve | | - | | 0.0% | | (812) | | ($0.07) |
GAAP measure | | $ 10,747 | | 4.4% | | $ 8,810 | | $0.75 |
Main: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
10
(Table 2 continued)
| | | | | | | | | | |
Third Quarter Fiscal 2014 | | | | | | | | |
Dollars in thousands, except EPS | | KMG Chemicals, Inc. |
| | | | | | | | |
| | Operating | | Net | | Diluted Earnings |
| | Income | | Margin | | Income | Per Share |
Non-GAAP measure | | $ 4,333 | | 5.1% | | $ 2,388 | | $0.20 |
Restructuring charges | | (1,061) | | (1.2%) | | (691) | | ($0.06) |
Restructuring income tax expense | | - | | 0.0% | | (238) | | ($0.02) |
Acquisition & integration expenses | | (358) | | (0.4%) | | (233) | | ($0.01) |
GAAP measure | | $ 2,914 | | 3.5% | | $ 1,226 | | $0.11 |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | Electronic Chemicals | | Wood Treating Chemicals |
| | Operating | | Operating |
| | Income | | Margin | | Income | | Margin |
Non-GAAP measure | | $ 3,429 | | 5.6% | | $ 2,092 | | 9.2% |
Integration expenses | | (254) | | (0.4%) | | - | | 0.0% |
GAAP measure | | $ 3,175 | | 5.2% | | $ 2,092 | | 9.2% |
| | | | | | | | |
Nine Months Ended April 30, 2014 | | | | | | | | |
Dollars in thousands, except EPS | | KMG Chemicals, Inc. |
| | | | | | | | |
| | Operating | | Net | | Diluted Earnings |
| | Income | | Margin | | Income (Loss) | (Loss) Per Share |
Non-GAAP measure | | $ 11,756 | | 4.5% | | $ 6,295 | | $0.54 |
Restructuring charges | | (5,092) | | (1.9%) | | (4,965) | | ($0.42) |
Integration expenses | | (1,018) | | (0.4%) | | (663) | | ($0.06) |
CEO transition costs | | (1,280) | | (0.5%) | | (833) | | ($0.07) |
GAAP measure | | $ 4,366 | | 1.7% | | $ (166) | | ($0.01) |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | Electronic Chemicals | | Wood Treating Chemicals |
| | Operating | | Operating |
| | Income | | Margin | | Income | | Margin |
Non-GAAP measure | | $ 10,422 | | 5.6% | | $ 5,708 | | 7.6% |
Integration expenses | | (914) | | (0.5%) | | - | | 0.0% |
GAAP measure | | $ 9,508 | | 5.1% | | $ 5,708 | | 7.6% |
KMG Chemicals, Inc.
Eric Glover, 713-600-3865
Investor Relations Manager
eglover@kmgchemicals.com
Main: 713-600-3800 ● Fax: 713-600-3850
www.kmgchemicals.com ● NYSE: KMG
11